Mandala art therapy to boost resilience and coping around colorectal cancer surgery
Official title: The Effect of Mandala Art Therapy on Psychological Resilience and Coping With Cancer in Patients Undergoing Colorectal Cancer Surgery: a Prospective Randomized Controlled Study.
Run by Cumhuriyet University · NCT07535021 · Data updated 2026-11-12
This trial tests whether mandala art therapy can help adults having colorectal cancer surgery feel more resilient and cope better with their illness.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 74 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Cumhuriyet University Academic / other |
| Locations | 1 site (Sivas) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | June 2026 |
| Study ends | December 2026 |
| Registry record updated | April 16, 2026 |
| Trial ID | NCT07535021 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–74 scheduled for colorectal cancer surgery who can communicate, have no significant visual or upper-limb impairments, no history of psychotic drug use or prior psychiatric diagnosis, and expect at least a three-day postoperative hospital stay.
✕Probably not a fit
Patients older than 74, those with prior psychiatric diagnoses, significant visual or upper-limb impairments, uncontrolled pain or fatigue (VAS >3) before the intervention, or those unable/unwilling to complete the mandala sessions are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized controlled, pre-test–post-test trial comparing mandala art therapy plus routine care to routine care alone for patients undergoing colorectal cancer surgery. Seventy adults will be enrolled (planned 35 per group) based on a power calculation to detect a medium effect size, with outcomes measured before and after the intervention. Eligible participants are adults scheduled for colorectal cancer surgery who can communicate, have no significant visual or upper-extremity impairments, and will remain hospitalized for three days postoperatively. The primary outcomes focus on psychological resilience and coping with cancer, with standard instruments administered at baseline and after the intervention during the 2026 enrollment period.
Why it matters
Potential benefit: If successful, participants may experience improved psychological resilience and better coping after colorectal cancer surgery, which could reduce distress and support recovery.
How similar studies have gone: Small randomized and controlled studies of mandala or other art therapies in cancer and medical populations have reported modest improvements in mood and coping, but large definitive trials are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * To communicate, * Aged 18 or older, * Agreed to participate * Scheduled for colorectal cancer surgery. * No physical disability of the upper extremities, * no visual problems, * no history of psychotic drug use, * pain intensity and fatigue level ≤3 points according to VAS-10 before MST application, * will be hospitalized for 3 days postoperatively, Exclusion Criteria: * Over 74 years old, * has not completed mandala art therapy application, * is not compliant with the application, * has a history of previous psychiatric diagnosis.
Where it's running
-
Sivas Cumhuriyet University
Sivas, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Pınar YILMAZ EKER — Cumhuriyet University
- Study coordinator: Pınar YILMAZ EKER
- Email: yilmazpinar20@gmail.com
- Phone: +90 530 946 89 19
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Knife-assisted full-thickness resection for rectal lesions in a multicenter setting
A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.
-
Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model
This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.
-
Integrated genomic and clinical database for cancer biomarker discovery
Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
Liver transplantation for colorectal cancer with liver metastases
This study follows adults with stage IV colorectal cancer whose disease is limited to the liver and who are getting a liver transplant as part of their cancer care to see how they fare over time.
-
LTZ-232: a first-in-human test in advanced colorectal and other solid tumors
A first-in-human study tests LTZ-232, a new therapy for adults with unresectable or metastatic colorectal cancer and other solid tumors that have not responded to standard treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.